Adamis Pharmaceuticals Corp - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ADMP Nasdaq 2834 http://www.adamispharmaceuticals.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Adamis Pharmaceuticals Corp

Edited Transcript of ADMP earnings conference call or presentation 12-Nov-19 10:00pm GMT - Dec 4th, 2019 4:45 am
Maxim’s Bullish Stance on Adamis (ADMP) Stock Comes to an End - Nov 27th, 2019 10:09 pm
Adamis shares tumble after letter from FDA - Nov 25th, 2019 8:16 pm
UPDATE 1-FDA declines to approve Adamis Pharma's Zimhi to treat opioid overdose - Nov 25th, 2019 1:44 pm
Adamis Pharmaceuticals Receives a Complete Response Letter from the FDA Regarding ZIMHI - Nov 25th, 2019 1:00 pm
Adamis Pharmaceuticals Announces Publication of Comparative Pharmacokinetics of Community Use Naloxone Formulations - Nov 18th, 2019 2:00 pm
Adamis Pharmaceuticals (ADMP) Reports Q3 Loss, Misses Revenue Estimates - Nov 13th, 2019 12:05 am
Adamis Pharmaceuticals Announces Third Quarter 2019 Financial Results and Business Update - Nov 12th, 2019 9:28 pm
Implied Volatility Surging for Adamis Pharmaceuticals (ADMP) Stock Options - Nov 7th, 2019 1:54 pm
Adamis Pharmaceuticals Schedules Third Quarter 2019 Earnings Conference Call and Business Update - Nov 6th, 2019 9:05 pm
The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 Disappointment - Nov 5th, 2019 11:53 am
Adamis Pharmaceuticals Provides Regulatory Update for Its Higher Dose Naloxone Pre-Filled Syringe - Nov 5th, 2019 1:00 am
Will Adamis Pharmaceuticals (ADMP) Report Negative Q3 Earnings? What You Should Know - Nov 1st, 2019 2:30 pm
Could The Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Ownership Structure Tell Us Something Useful? - Oct 18th, 2019 10:26 am
Adamis Pharmaceuticals Announces Presentation of ZIMHI data at IHV Scientific Meeting - Oct 8th, 2019 1:00 pm
Adamis Pharmaceuticals Announces Commercial Partnership with Emerge Health for SYMJEPI® in Australia and New Zealand - Oct 1st, 2019 1:00 pm
Adamis Pharmaceuticals Announces Presentation Pertaining to Its High Dose Naloxone Product Candidate at IHV Scientific Meeting - Sep 26th, 2019 1:00 pm
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP): What Does Its Beta Value Mean For Your Portfolio? - Sep 12th, 2019 10:20 am
Adamis Pharmaceuticals Provides Update for Naloxone Product Candidate - Sep 3rd, 2019 1:00 pm
Adamis Pharmaceuticals Provides Launch and Marketing Update for SYMJEPI - Aug 28th, 2019 1:00 pm